Abstract
The cancer stem cell hypothesis has become popular in the past few years, in part to provide an explanation of the recurrence of the disease following initial remission and apparent cure. Nevertheless, the concept that cancer is a developmental disease resulting from aberrant control of cellular differentiation is old and is epitomized by teratocarcinomas, a form of testicular germ cell tumor, and by the hematological malignancies. These ideas have developed in parallel with the notion of tissue stem cells that provide for the replacement of functional cells in adult tissues, especially in those tissues subject to continual ‘wear and tear’ throughout adult life. Although a simple view might hold that cancers contain a small population of cancer initiating stem cells equivalent to and, perhaps, derived from the stem cells of the tissue from which they arise, the circumstances of such cancer stem cells is inevitably very different from those of tissue stem cells. Consequently the possibility that a tumor can be composed entirely of oxymoronic nullipotent stem cells is still compatible with a stem cell view of cancer initiation and progression. This review considers the origins of the cancer stem cell concept, and issues that need to be addressed to enhance its utility for developing methods for preventing and treating cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hethcote HW, Knudson AG Jr. Model for the incidence of embryonal cancers: application to retinoblastoma. Proc Natl Acad Sci USA 1978; 75:2453–7.
Ailles LE, Irving L, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18:460–6.
Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirage or reality? Nat Med 2009; 15:1010–2.
Lajtha LG. Stem cell concepts. Differentiation 1979; 14:23–34.
Potten CS, Lajtha LG. Stem cells versus stem lines. Ann NY Acad Sci 1982; 397:47–60.
Cairns J. Mutation selection and the natural history of cancer. Nature 1975; 255:197–200.
Zhou BBS, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discovery 2009; 8:806–23.
Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumor formation by single human melanoma cells. Nature 2008; 456:593–8.
Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties: Lessons for and from the Crypt. Development 1990; 110:1001–20.
Jones PH, Simons BD, Watt FM. Sic transit gloria: farewell to the epidermal transit amplifying cell? Cell Stem Cell 2007; 1:371–81.
Andrews PW. From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B 2002; 357:405–17.
Stevens LC, Little CC. Spontaneous testicular teratomas in an inbred strain of mice. Proc Natl Acad Sci USA 1954; 40:1080–7.
Kleinsmith LJ, Pierce GB. Multipotentiality of single embryonal carcinoma cells. Cancer Res 1964; 24:1544–52.
Solter D. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat Rev Genet 2006; 7:319–27.
Martin GR, Evans MJ. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci USA 1975; 72:1441–5.
Damjanov I. Teratocarcinoma stem cells. Cancer Surv 1990; 9:303–19.
McCulloch EA, Till JE. The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiat Res 1960; 13:115–25.
Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961; 14:213–22.
Greaves MF. Stem cell origins of leukaemia and curability. Br J Cancer 1993; 67:413–23.
Wang JCY, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005; 15:494–501.
Glauche I, Moore K, Thielecke L, Horn K, Loeffler M, Roeder I. Stem cell proliferation and quiescence – two sides of the same coin. PLoS Comput Biol 2009; 5:e1000447.
Markert CL. Neoplasia: a disease of cell differentiation. Cancer Res 1968; 28:1908–14.
Pierce GB. Neoplasms, differentiations and mutations. Am J Pathol 1974; 77:103–18.
Powell AE, Shung CY, Saylor KW, Müllendorf KA, Weiss JB, Wong MH. Lessons from development: A role for asymmetric stem cell division in cancer. Stem Cell Res 2009 Sep 25. [Epub ahead of print] PMID: 19853549.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Andrews, P.W. (2011). Treating Oncologic Disease. In: Hug, K., Hermerén, G. (eds) Translational Stem Cell Research. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-959-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-60761-959-8_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-958-1
Online ISBN: 978-1-60761-959-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)